Rankings
▼
Calendar
RVMD Q4 2020 Earnings — Revolution Medicines, Inc. Revenue & Financial Results | Market Cap Arena
RVMD
Revolution Medicines, Inc.
$20B
Q4 2020 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$9M
-27.6% YoY
Gross Profit
$9M
100.0% margin
Operating Income
-$34M
-389.4% margin
Net Income
-$34M
-390.9% margin
EPS (Diluted)
$-0.52
QoQ Revenue Growth
-30.9%
Cash Flow
Operating Cash Flow
-$25M
Free Cash Flow
-$26M
Stock-Based Comp.
$3M
Balance Sheet
Total Assets
$567M
Total Liabilities
$93M
Stockholders' Equity
$475M
Cash & Equivalents
$104M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$9M
$12M
-27.6%
Gross Profit
$9M
$12M
-27.6%
Operating Income
-$34M
-$20M
-74.2%
Net Income
-$34M
-$15M
-134.3%
Revenue Segments
Collaboration Revenue Related Party
$9M
100%
← FY 2020
All Quarters
Q1 2021 →